# Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

> **NCT03541850** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 92 (actual)

## Conditions studied

- PSA Level Greater Than 0.03
- PSA Progression
- Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7
- Stage II Prostate Adenocarcinoma AJCC v7
- Stage III Prostate Adenocarcinoma AJCC v7

## Interventions

- **DRUG:** Antiandrogen Therapy
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT03541850
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-29
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541850, "Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03541850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*